Abstract PR001: Exploiting HIF-driven endogenous retroviral neoantigens to advance kidney cancer immunotherapy
Qinqin Jiang(Dana-Farber Cancer Institute), William G. Kaelin(Broad Institute), Nicholas J. Kramer(Harvard University), Jennifer G. Abelin(Broad Institute), Melissa Carr-Reynolds(TScan Therapeutics (United States)), Nancy Nabilsi(TScan Therapeutics (United States)), Vipheaviny Chea(Dana-Farber Cancer Institute), Isabel Carulli(Dana-Farber Cancer Institute), Susan Klaeger(Broad Institute), Gürcan Günaydın(Dana-Farber Cancer Institute), Yijia Jiang(Dana-Farber Cancer Institute), Gavin MacBeath(TScan Therapeutics (United States)), Nawoo Kim(Dana-Farber Cancer Institute), Sudeepa Syamala(Dana-Farber Cancer Institute), B Bernstein(Broad Institute), Eva K. Verzani(Broad Institute), Kshiti Meera Phulphagar(Broad Institute), Melissa B. Pappalardi(GlaxoSmithKline (United States)), Justin S. Becker(Dana-Farber Cancer Institute), Joseph E. Duke-Cohan(Dana-Farber Cancer Institute), Nitin H. Shirole(Broad Institute), Jonathan Stevens(Brigham and Women's Hospital), Cagan Gurer(Regeneron (United States)), Vijyendra Ramesh(Duke University), Zachary T. Herbert(Dana-Farber Cancer Institute), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), William A. Freed-Pastor(Broad Institute), Sabrina Y. Camp(Dana-Farber Cancer Institute), Kevin Meli(Massachusetts Institute of Technology), Sudarsana Addepalli(Dana-Farber Cancer Institute), Isabelle E Lippincott(Broad Institute), Richard Childs(National Institutes of Health), Cleo Forman(Dana-Farber Cancer Institute), Allison P. Vanasse(Dana-Farber Cancer Institute), Eddy Saad(Dana-Farber Cancer Institute), Xintao Qiu(Dana-Farber Cancer Institute), P. Cejas(Dana-Farber Cancer Institute), H. W. Long(Dana-Farber Cancer Institute), R. Li(Dana-Farber Cancer Institute), Steven Carr(Broad Institute), William Lane(Brigham and Women's Hospital), Catherine Wu(Dana-Farber Cancer Institute), David A. Braun, L. Stirling Churchman(Harvard University), Eliezer Van Allen(Dana-Farber Cancer Institute), Karl Clauser(Broad Institute), Derin Keskin(Dana-Farber Cancer Institute), Teagan Parsons(University of Massachusetts Chan Medical School), Toni K. Choueiri(Dana-Farber Cancer Institute), Suzanna Rachimi(Broad Institute)
Cited by 0
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Comprehensive Mapping of Long-Range Interactions Reveals Folding Principles of the Human Genome
|Science|2009|9.6k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k